- Presentations
- 6
- Markets
- 1
Imbruvica is a brand of Ibrutinib marketed by Pharmacyclics, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ibrutinib
- Brand owner
- Pharmacyclics
- Registered in
- United States
- Strengths and forms
- 140 mg capsule, 70 mg capsule, 70 mg/mL oral suspension, 140 mg tablet, 280 mg tablet, 420 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Imbruvica 140 mg capsuleOral | Pharmacyclics | US FDA | Available on request |
| Imbruvica 70 mg capsuleOral | Pharmacyclics | US FDA | Available on request |
| Imbruvica 70 mg/mL oral suspensionOral | Pharmacyclics | US FDA | Available on request |
| Imbruvica 140 mg tabletOral | Pharmacyclics | US FDA | Available on request |
| Imbruvica 280 mg tabletOral | Pharmacyclics | US FDA | Available on request |
| Imbruvica 420 mg tabletOral | Pharmacyclics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Imbruvica
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.